Evidence map›Paper›PMID 33149219›Full record

ArticleScientific reports2020

Evolution from adherent to suspension: systems biology of HEK293 cell line development.

Magdalena Malm, Rasool Saghaleyni, Magnus Lundqvist, Marco Giudici, Veronique Chotteau, Ray Field, Paul G Varley, Diane Hatton, Luigi Grassi, Thomas Svensson and 2 more

Erratum issuedOpen access · goldAbstract readComparative Study
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 107 citations in OpenAlex.

  1. Article
  2. CRISPR-Cas9 screening revealsMolecular therapy. Advances · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. TiOBioprocess and biosystems engineering · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Comparative Analysis of HEK293 Genomic Variability.Biotechnology and bioengineering · 2026
    Article
  12. Integrated Modular Workflows for Membrane Protein Production in HEK293 Cells.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Specific Instability of HLA-A*03:01 Expression in HEK-293 Cells.International journal of molecular sciences · 2025
    Article
  17. Article
  18. PlasmaArteriosclerosis, thrombosis, and vascular biology · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Magdalena Malm *KTH - School of Engineering Sciences in Chemistry, Biotechnology, and Health, Dept. of Protein Science, Royal Institute of Technology, 106 91, Stockholm, Sweden.
Rasool Saghaleyni *Department of Biology and Biological Engineering, Chalmers University of Technology, 412 96, Gothenburg, Sweden.
Magnus LundqvistKTH - School of Engineering Sciences in Chemistry, Biotechnology, and Health, Dept. of Protein Science, Royal Institute of Technology, 106 91, Stockholm, Sweden.
Marco GiudiciKTH - School of Engineering Sciences in Chemistry, Biotechnology, and Health, Dept. of Protein Science, Royal Institute of Technology, 106 91, Stockholm, Sweden.
Veronique ChotteauKTH - School of Engineering Sciences in Chemistry, Biotechnology, and Health, Dept. of Protein Science, Royal Institute of Technology, 106 91, Stockholm, Sweden.
Ray FieldBiopharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Milstein Building, Granta Park, Cambridge, CB21 6GH, UK.
Paul G VarleyBiopharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Milstein Building, Granta Park, Cambridge, CB21 6GH, UK.
Diane HattonBiopharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Milstein Building, Granta Park, Cambridge, CB21 6GH, UK.
Luigi GrassiBiopharmaceutical Development, BioPharmaceuticals R&D, AstraZeneca, Milstein Building, Granta Park, Cambridge, CB21 6GH, UK.
Thomas SvenssonDepartment of Biology and Biological Engineering, Chalmers University of Technology, 412 96, Gothenburg, Sweden.
Jens NielsenDepartment of Biology and Biological Engineering, Chalmers University of Technology, 412 96, Gothenburg, Sweden. nielsenj@chalmers.se.
Johan RockbergKTH - School of Engineering Sciences in Chemistry, Biotechnology, and Health, Dept. of Protein Science, Royal Institute of Technology, 106 91, Stockholm, Sweden. johan.rockberg@biotech.kth.se.
KTH Royal Institute of Technology · SEAstraZeneca (United Kingdom) · GBChalmers University of Technology · SENovo Nordisk Foundation · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The need for new safe and efficacious therapies has led to an increased focus on biologics produced in mammalian cells. The human cell line HEK293 has bio-synthetic potential for human-like production attributes and is currently used for manufacturing of several therapeutic proteins and viral vectors. Despite the increased popularity of this strain we still have limited knowledge on the genetic composition of its derivatives. Here we present a genomic, transcriptomic and metabolic gene analysis of six of the most widely used HEK293 cell lines. Changes in gene copy and expression between industrial progeny cell lines and the original HEK293 were associated with cellular component organization, cell motility and cell adhesion. Changes in gene expression between adherent and suspension derivatives highlighted switching in cholesterol biosynthesis and expression of five key genes (RARG, ID1, ZIC1, LOX and DHRS3), a pattern validated in 63 human adherent or suspension cell lines of other origin.

Indexed as

Cell AdhesionCell Culture TechniquesCell MovementCholesterolGene DosageGene Expression ProfilingGene Expression RegulationGene Regulatory NetworksHEK293 CellsHumansMetabolomicsProtein EngineeringCholesterol

Identifiers

PMID33149219
PMCPMC7642379
OpenAlexW3097369531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.